The association between beta-blockers and outcomes in patients with heart failure and concurrent Alzheimer's disease and related dementias.

Lauren GilstrapAndrew B Cohen Gregory M Ouellet Parag GoyalBarbara GladdersDanette FlintJonathan Skinner

Published in: Journal of the American Geriatrics Society (2022)

BB therapy is associated with significantly lower short and long-term mortality rates among all patients with HFrEF; the magnitude of these associated benefits appear at least as large in patients with HFrEF and ADRD compared to patients with HFrEF-only.

Keyphrases

growth factor
cognitive decline
angiotensin converting enzyme
locally advanced
risk factors
squamous cell carcinoma
type diabetes
mesenchymal stem cells
metabolic syndrome
skeletal muscle
adipose tissue
angiotensin ii
cell therapy
glycemic control